SPIROPIPERIDINES AS HIGH-AFFINITY, SELECTIVE SIGMA-LIGANDS

被引:75
作者
CHAMBERS, MS [1 ]
BAKER, R [1 ]
BILLINGTON, DC [1 ]
KNIGHT, AK [1 ]
MIDDLEMISS, DN [1 ]
WONG, EHF [1 ]
机构
[1] MERCK SHARP & DOHME LTD,NEUROSCI RES CTR,DEPT BIOCHEM,HARLOW CM20 2QR,ESSEX,ENGLAND
关键词
D O I
10.1021/jm00089a013
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A variety of achiral conformationally restricted spirocyclic piperidines have been prepared in an attempt to investigate the functional role of the central sigma-recognition site. All the compounds possessed a lipophilic N-substituent incorporating either a tetralin, indan, or benzocycloheptane skeleton. Their in vitro affinity at the sigma-site was assessed in radioligand displacement experiments with guinea pig cerebellum homogenates using the sigma-specific radioligand [H-3]-N,N'-di-o-tolyguanidine ([H-3]-DTG, [H-3]-6). A study of the structure-activity relationships identified the N-butyl and N-dimethylallyl substituents as the optimum groups for high affinity and selectivity at the sigma-site (e.g., 3,4-dihydro-1'-(3-methylbut-2-enyl)spiro[1H-indene-1,4'-piperidine] (48), pIC50 = 8.9 vs [3H]-6 and greater than 10000-fold selective over the dopamine D2 receptor). Such compounds are amongst the highest affinity sigma-ligands reported to date, with excellent selectivity over the dopamine D2 receptor, and may serve as at useful tool for exploring the physiological role of the sigma-site.
引用
收藏
页码:2033 / 2039
页数:7
相关论文
共 31 条
[1]   NUCLEAR MAGNETIC RESONANCE STUDIES OF SPIRO(TETRALIN-I,4'-PIPERIDINE) COMPOUNDS [J].
AINSWORT.C ;
HACKLER, RE ;
BOAZ, HE .
JOURNAL OF ORGANIC CHEMISTRY, 1966, 31 (10) :3345-&
[2]   REDUCTION OF TOSYLHYDRAZONES AND OF ACYL TOSYLHYDRAZIDES [J].
CAGLIOTI, L .
TETRAHEDRON, 1966, 22 (02) :487-&
[4]   PSYCHOTOMIMETIC EFFECTS AND SIGMA LIGANDS [J].
CONNICK, J ;
FOX, P ;
NICHOLSON, D .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (07) :274-275
[5]  
COSTA BR, 1990, J MED CHEM, V33, P3100
[6]  
HASHIGAKI K, 1984, CHEM PHARM BULL, V32, P3561
[7]  
HAUNGMINLON, 1949, J AM CHEM SOC, V71, P3301
[8]  
HUANGMINLON, 1946, J AM CHEM SOC, V68, P2487, DOI DOI 10.1021/JA01216A013
[9]  
JANSSEN C, 1964, Patent No. 1335831
[10]  
LARGENT BL, 1987, MOL PHARMACOL, V32, P772